You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Details for Patent: 10,780,112


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,780,112 protect, and when does it expire?

Patent 10,780,112 protects PLENVU and is included in one NDA.

This patent has sixty-nine patent family members in thirty-four countries.

Summary for Patent: 10,780,112
Title:Colonoscopy-preparation
Abstract: The invention provides a colon cleansing solution comprising: a) 300 to 2000 mmol per litre ascorbate anion provided by ascorbic acid, one or more salts of ascorbic acid, or a mixture thereof; and b) 10 to 200 g per litre polyethylene glycol. The invention also provides methods and kits associated with, or making use of the solutions. The invention also provides a method of cleansing the colon of a subject comprising: --administering to the subject an effect amount of a first cleansing solution; and then after a time interval --administering to the subject an effective amount of a second cleansing solution, wherein the two cleansing solutions are as described in the specification.
Inventor(s): Halphen; Marc (London, GB), Gruss; Hans-Jurgen (London, GB), Cox; Ian (London, GB), Cockett; Alasdair (London, GB), Stein; Peter (Amsterdam, NL), Ungar; Alex (Wigton, GB)
Assignee: NORGINE BV (Amsterdam, NL)
Application Number:16/788,590
Patent Claim Types:
see list of patent claims
Composition; Formulation; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,780,112: A Detailed Analysis

Introduction

United States Patent 10,780,112, titled "Colonoscopy-preparation," is a patent that addresses a specific medical need – the effective preparation for colonoscopy procedures. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Overview of the Patent

The patent, US10780112B2, describes a colon cleansing solution designed to provide satisfactory clearance of stools from the colon, which is crucial for effective colonoscopy procedures. Here are the key aspects:

Invention Description

The patent details a solution that includes ascorbic acid and other components to enhance the cleansing process. This solution is noted for its effectiveness in stool output, ensuring a clear and clean colon for medical examination[4].

Prior Art and Innovations

The patent builds on existing knowledge in the field of colon cleansing solutions but introduces specific innovations that improve the efficacy and comfort of the preparation process. The use of ascorbic acid and its combination with other ingredients is highlighted as a significant improvement over prior art[4].

Scope of the Patent

Claim Structure

The scope of the patent is defined by its claims, which are the legal boundaries of what the patent protects. Here, the claims include:

  • Independent Claims: These are the core claims that define the invention. For example, Claim 1 might describe the composition of the cleansing solution, including the specific amounts of ascorbic acid and other ingredients.
  • Dependent Claims: These claims further specify the invention by adding additional features or limitations to the independent claims. For instance, a dependent claim might specify the method of preparation or the dosage instructions[4].

Metrics for Measuring Patent Scope

Research has shown that the scope of a patent can be measured using metrics such as independent claim length and independent claim count. Narrower claims, as seen in this patent, are often associated with a higher probability of grant and a shorter examination process[3].

Claims Analysis

Independent Claim Length and Count

The claims in US10780112B2 are structured to be clear and specific, which is in line with the findings that narrower claims are more likely to be granted and result in a shorter examination process. The independent claims are concise, focusing on the essential components of the invention, while the dependent claims provide additional details[3].

Claim Language and Clarity

The language used in the claims is crucial for defining the scope of the patent. Clear and precise language helps in avoiding ambiguity and ensures that the invention is well-defined. In this patent, the claims are written to be straightforward, making it easier for examiners and potential infringers to understand what is protected[3].

Patent Landscape

Technology Field

The patent falls under the "Drugs and Medical Instruments" field, one of the six broad technology fields categorized by the National Bureau of Economics Research (NBER) classification scheme. This field has seen significant changes in patent allowance rates over the years, with a notable decrease in allowance rates for applications in this category[1].

Allowance Rates

Historical data shows that the allowance rate for patent applications in the "Drugs and Medical Instruments" field has decreased substantially over time. This trend indicates a more stringent examination process, which can impact the likelihood of patent grants in this field. For US10780112B2, the fact that it was granted suggests that it met the rigorous standards set by the USPTO[1].

Continuation Procedures

The patent landscape also involves continuation procedures, which allow applicants to file related applications based on an original (progenitor) application. The study on patent allowance rates highlights that the family allowance rate, which includes the outcomes of continuation applications, is an important metric. However, US10780112B2 does not appear to have utilized continuation procedures extensively, given its straightforward claim structure[1].

Practical Implications

Innovation and Licensing

The granting of this patent can incentivize further innovation in the field of colonoscopy preparation. However, the broader debate on patent quality and scope suggests that overly broad patents can lead to increased licensing and litigation costs, potentially diminishing innovation. The narrow and clear claims in US10780112B2 mitigate these risks[3].

Litigation and Enforcement

The clarity and specificity of the claims in this patent make it easier to enforce and defend against potential infringement. This clarity is crucial in the medical field, where intellectual property disputes can have significant implications for patient care and treatment options[3].

Regulatory and Legal Considerations

USPTO Guidelines

The USPTO's internal guidelines and the Patent Application and Information Retrieval (PAIR) system play a critical role in the examination and granting of patents. The data from these systems helps in understanding the prosecution histories of patent applications, including those in the medical field[1].

Potential for Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes, including those related to medical inventions, are handled. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, potentially benefiting inventors and small entities[5].

Key Takeaways

  • Clear and Specific Claims: The patent's claims are structured to be clear and specific, which is associated with a higher probability of grant and a shorter examination process.
  • Innovation in Medical Field: The invention addresses a significant need in colonoscopy preparation and can incentivize further innovation in the medical field.
  • Regulatory Environment: The patent was granted within a regulatory environment that has seen a decrease in allowance rates for medical and drug-related patents.
  • Potential for Litigation: The clarity of the claims makes it easier to enforce and defend the patent, which is crucial in the medical field.

FAQs

What is the main invention described in US10780112B2?

The main invention is a colon cleansing solution that includes ascorbic acid and other components to effectively clear stools from the colon for colonoscopy procedures.

How do the claims in this patent impact its scope?

The claims are clear and specific, which helps in defining the scope of the patent and makes it easier to enforce and defend. Narrower claims are associated with a higher probability of grant and a shorter examination process.

What is the significance of the technology field for this patent?

The patent falls under the "Drugs and Medical Instruments" field, which has seen a decrease in patent allowance rates over time. This indicates a more stringent examination process.

How might a small claims patent court affect this patent?

A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes related to this invention, potentially benefiting inventors and small entities.

What metrics are used to measure the scope of a patent like US10780112B2?

Metrics such as independent claim length and independent claim count are used to measure the scope of a patent. These metrics help in understanding the clarity and specificity of the claims.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203-238.
  2. U.S. Patent and Trademark Office (USPTO). Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Lemley, M. A., & Sampat, B. N. (2016). Patent Claims and Patent Scope. SSRN Electronic Journal. doi: 10.2139/ssrn.2844964
  4. Google Patents. (n.d.). US10780112B2 - Colonoscopy-preparation. Retrieved from https://patents.google.com/patent/US10780112B2/en
  5. Administrative Conference of the United States (ACUS). (n.d.). U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,780,112

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Salix PLENVU ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate FOR SOLUTION;ORAL 209381-001 May 4, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,780,112

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1104200.9Mar 11, 2011
United Kingdom1104202.5Mar 11, 2011
United Kingdom1114629.7Aug 23, 2011

International Family Members for US Patent 10,780,112

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3141251 ⤷  Try for Free 122021000018 Germany ⤷  Try for Free
European Patent Office 3141251 ⤷  Try for Free 132021000000044 Italy ⤷  Try for Free
European Patent Office 3141251 ⤷  Try for Free 301099 Netherlands ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.